milvexian
janssen,bms
['milvexian', 'bristol', '$jnj', '$bmy']
bristol myers squibbs' anticoagulant milvexian failed its phase 2 trial but accrued enough encouraging data for the company to prep phase 3 plans $bmy $jnj 
Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at https://t.co/7Q6gUQgCIU